These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6107939)

  • 1. Antiarrhythmic action of adrenergic beta-receptor blocking agents.
    Seth SD
    Pharmacol Ther; 1980; 11(1):159-79. PubMed ID: 6107939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of cardiac glycosides and the process of adrenergic mediation (a review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1977; 40(6):733-45. PubMed ID: 23310
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic mechanisms of beta blocker therapy.
    Grandi E; Ripplinger CM
    Pharmacol Res; 2019 Aug; 146():104274. PubMed ID: 31100336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of beta-blocker an as antiarrhythmic agent].
    Okazaki O; Akatsuka N
    Nihon Rinsho; 1996 Aug; 54(8):2117-24. PubMed ID: 8810786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C; Lichstein E
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.
    Singh BN; Sarma JS
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):69-87. PubMed ID: 11452339
    [No Abstract]   [Full Text] [Related]  

  • 9. [EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.].
    Popova EP; Fisenko VP
    Eksp Klin Farmakol; 2016; 79(11):26-34. PubMed ID: 29791106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?
    Szentmiklosi AJ; Szentandrássy N; Hegyi B; Horvath B; Magyar J; Bányász T; Nanasi PP
    Curr Pharm Des; 2015; 21(8):1030-41. PubMed ID: 25354180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blockers in acute myocardial infarction.
    Jariwala PV; Lathi P; Ramesh G; Saha D; Chandra KS
    Indian Heart J; 2010; 62(2):148-53. PubMed ID: 21180308
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drugs: electrophysiological basis of their clinical usage.
    Weng JT; Smith DE; Moulder PV
    Ann Thorac Surg; 1986 Jan; 41(1):106-12. PubMed ID: 2417568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug therapy (Part 1). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Sep; 88(3):452-60. PubMed ID: 2863091
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of antiarrhythmic drug effects by beta-adrenergic sympathetic stimulation.
    Sager PT
    Am J Cardiol; 1998 Aug; 82(4A):20I-30I. PubMed ID: 9737651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction.
    van Dijk L
    Folia Med Neerl; 1971; 14(5):225-36. PubMed ID: 4400908
    [No Abstract]   [Full Text] [Related]  

  • 19. Special article. The role of beta-adrenergic blockade in myocardial infarction.
    Jewitt DE; Singh BN
    Prog Cardiovasc Dis; 1974; 16(4):421-38. PubMed ID: 4153071
    [No Abstract]   [Full Text] [Related]  

  • 20. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II.
    Morgan PH; Mathison IW
    J Pharm Sci; 1976 May; 65(5):635-48. PubMed ID: 6770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.